B

BMC Medical Co Ltd
SZSE:301367

Watchlist Manager
BMC Medical Co Ltd
SZSE:301367
Watchlist
Price: 67.98 CNY 0.67% Market Closed
Market Cap: 6.1B CNY
Have any thoughts about
BMC Medical Co Ltd?
Write Note

BMC Medical Co Ltd
Other Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

BMC Medical Co Ltd
Other Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Receivables CAGR 3Y CAGR 5Y CAGR 10Y
B
BMC Medical Co Ltd
SZSE:301367
Other Receivables
ÂĄ27.4m
CAGR 3-Years
30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Other Receivables
ÂĄ9.1m
CAGR 3-Years
15%
CAGR 5-Years
14%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Other Receivables
ÂĄ258.9m
CAGR 3-Years
-18%
CAGR 5-Years
6%
CAGR 10-Years
-4%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Other Receivables
ÂĄ660.3m
CAGR 3-Years
7%
CAGR 5-Years
18%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Other Receivables
ÂĄ48m
CAGR 3-Years
0%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Other Receivables
ÂĄ376.3m
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

BMC Medical Co Ltd
Glance View

Market Cap
6.1B CNY
Industry
Health Care

BMC Medical Co. Ltd. principally engages in the research, development, production, and sale of medical equipment and consumable products in the field of respiratory health. The company is headquartered in Beijing, Beijing and currently employs 843 full-time employees. The company went IPO on 2022-11-01. The firm's products mainly include non-invasive home ventilators, ventilation masks, sleep monitors and high-flow humidified oxygen therapy devices. The firm also provides respiratory health chronic disease management services. The firm focuses on the treatment of patients with sleep apnea-hypopnea syndrome (SAHS), mainly obstructive sleep apnea syndrome (OSA), as well as patients with respiratory insufficiency, mainly chronic obstructive pulmonary disease (COPD), providing a full-cycle and multi-scenario overall solution for treatment services.

Intrinsic Value
63.07 CNY
Overvaluation 7%
Intrinsic Value
Price
B

See Also

What is BMC Medical Co Ltd's Other Receivables?
Other Receivables
27.4m CNY

Based on the financial report for Dec 31, 2023, BMC Medical Co Ltd's Other Receivables amounts to 27.4m CNY.

What is BMC Medical Co Ltd's Other Receivables growth rate?
Other Receivables CAGR 3Y
30%

Over the last year, the Other Receivables growth was 17%. The average annual Other Receivables growth rates for BMC Medical Co Ltd have been 30% over the past three years .

Back to Top